• Home
  • Journal
  • Public Companies
  • BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada

BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada

22.10.2019BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in CanadaOur company BBS-Bioactive Bone Substitutes Plc’s patent application ”A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION CONTAINING POLYETHYLENE GLYCOL/GLYCEROL MATRIX AND CALCIUM SALT GRANULES” has been accepted in Canada. The same European and Eurasian patent has been valid about three years.CEO Ilkka Kangasniemi:
”This is positive news for our company. This approval in Canada strengthens the patent protection of our ARTEBONE® product and its unique component, bone protein extract, in the world.”
More information:Ilkka Kangasniemi, CEOtel. 040 7080307, e-mail: ilkka.kangasniemi@bbs-artebone.fi
Distribution:Nasdaq Helsinki OyNasdaq Stockholm ABMain Mediawww.bbs-artebone.fiThis is information that BBS-Bioactive Bone Substitutes Plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on 22nd October 2019 at 3:00 pm (UTC+2:00).BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic surgery. The research and development in the field of medicine requires perseverance and courage to develop new things.  We have over 20 years of expertise in this. Our operations are characterised by top expertise, innovativeness and dedicated and committed employees. The first product, ARTEBONE® paste, is ready and the application process for the CE-marking enabling commercialization is in progress. More information: www.bbs-artebone.com.BBS’ Certified Adviser at Nasdaq First North Growth Market Stockholm and Helsinki is Stockholm Certified Advisers AB, +46 70 5516 729, info@certifiedadviser.se.

Disclaimer & Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.